Expression of CXC chemokine ligand 16 and chemokine receptor 6 in periodontal tissues of patients with moderately severe periodontitis

Abstract

Abstract: PURPOSE: To investigate the expression and localization of CXCLl6 and its receptor CXCR6 in gingival tissues of patients with chronic periodontitis and analyze the roles in the occurrence and development of periodontitis. METHODS: Gingival tissues with moderately severe periodontitis were collected from 39 patients treated in People's Hospital of Liaoning Province. Forty persons with healthy gingiva were used as control. The age of the enrolled subjects ranged from 35 to 74 years old. Immunohistochemical technique was applied to detect the expression and localization of CXCLl6 and CXCR6 protein gingival tissues of all subjects. The data was analyzed with SPSS 15.0 software package. RESULTS: Compared with normal group, the expression of CXCLl6 and CXCR6 were significantly up-regulated in patients with periodontitis (P<0.05). There was a positive relationship between the protein expression of CXCLl6 and CXCR6 in gingival tissues of patients with periodontitis (r=0.580, P<0.05). CONCLUSIONS: CXCLl6 and CXCR6 may be involved in the development of chronic periodontitis. The expression of CXCLl6 and CXCR6 may work coordinately to promote the development of chronic periodontitis.

Key words: Periodontitis, Cytokines, CXCL16, CXCR6

CLC Number:

R781.4

SUN Xiao-ju,HOU Jun-chi,XIE Hong,ZHANG Hui,DENG Wei,WANG Yun. Expression of CXC chemokine ligand 16 and chemokine receptor 6 in periodontal tissues of patients with moderately severe periodontitis[J]. Shanghai Journal of Stomatology, 2015, 24(2): 193-198.

References

[1] 孟焕新.牙周病学[M]. 第4版.北京:人民卫生出版社, 2012: 12.
[2] Wilson M, Reddi K, Henderson B. Cytokine-inducing components of periodontopathogenic bacteria [J]. J Periodont Res, 1996, 31(6): 393-407.
[3] Taubman MA, Valverde P, Han X, et al. Immune response: the key to bone resorption in periodontal disease [J]. J Periodontol, 2005, 76(11 Suppl): 2033-2041.
[4] Taubman MA, Kawai T. Involvement of T-lymphocytes in periodontal disease and in direct and indirect induction of bone resorption [J]. Crit Rev Oral Biol Med, 2001, 12(2): 125-135.
[5] Rock KL, Latz E, Ontiveros F, et al. The sterile inflammatory response [J]. Annu Rev Immunol, 2010, 28: 321-342.
[6] Souza PP, Brechter AB, Reis RI, et al. IL-4 and IL-13 inhibit IL-1β and TNF-α induced kinin BIL-4 and IL-13 inhibit IL-1β and TNF-α induced kinin B1 and B2 receptors through a STAT6-dependent mechanism [J]. Br J Pharmacol, 2013, 169(2): 400-412.
[7] 黄煜, 李大金. 人早孕滋养细胞分泌趋化因子CXCL16促进自身增殖和侵袭 [J]. 分子细胞生物学报, 2006, 39(1): 15-21.
[8] Zhang L, Ran L, Garcia GE, et a1. Chemokine CXCLI6 regulates neutrophil and macrophage infiltration into injured muscle, promoting muscle regeneration [J]. Am J Pathol, 2009, 175(6): 2518-2527.
[9] Matloubian M, David A, Engel S, et a1. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo [J]. Nat Immuno1, 2000, 1(4): 298-304.
[10] Wilbanks A, Zondlo SC, Murphy K, et a1. Expression cloning of the STRL33/BONZO/TYMSTR ligand reveals elements of CC, CXC, and CX3C chemokines [J]. J Immunol,200l,166(8):5145-5154.
[11] Stricter RM, Burdick MD, Gomperts BN, et a1. CXC chemokines in angiogenesis [J]. Cytokine Growth Factor Rev, 2005, 16(6): 593-609.
[12] Hosokawa Y, Nakanishi T, Yamaguchi D, et al. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in periodontal diseased tissue [J]. Clin Exp Immunol, 2005, 139(3): 506-512.
[13] Hosokawa Y, Hosokawa I, Ozaki K, et al. CXCL12 and CXCR4 expression by human gingival fibroblasts in periodontal disease[J]. Clin Exp Immunol, 2005, 141(3): 467-474.
[14] Hosokawa Y, Hosokawa I, Ozaki K, et al. Increase of CCL20 expression by human gingival fibroblasts upon stimulation with cytokines and bacterial endotoxin [J]. Clin Exp Immunol, 2005, 142(2): 285-291.
[15] Schallhorn RA, Patel DN, Chandrasekar B, et al. Periodontal disease in association with systemic levels of interleukin-18 and CXC ligand 16 in patients undergoing cardiac catheterization [J]. J Periodontol, 2010, 81(8): 1180-1186.
[16] Hosokawa Y, Hosokawa I, Ozaki K, et al. CXC chemokine ligand 16 in periodontal diseases: expression in diseased tissues and production by cytokine-stimulated human gingival fibroblasts [J]. Clin Exp Immumol, 2007, 149(1): 146-154.
[17] Hosokawa Y, Hosokawa I, Ozaki K, et al. Human gingival fibroblasts express functional chemokine receptor CXCR6 [J]. Clin Exp Immunol, 2010, 156(3): 413-418.
[18] 孙琳. Raf/MEK/ERK信号通路对CXCL16诱导的CIA淋巴细胞增殖的影响[J]. 军医进修学院学报,2010, 31(11): 1113-1115.
[19] 司京玉, 聂生东, 陈瑛, 等. 免疫组织化学显微图像分析技术进展 [J]. 国际生物医学工程杂志, 2002, 25(3): 117-121.
[20] Shimaoka T, Nakayama T, Fukumoto N, et al. Cell surface-anchored SR-PSOX/C-XC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor6 expressing cells [J]. J Leukoc Biol, 2004, 75(2): 267-274.
[21] 刘芳. CXCL16/CXCR6与炎症性疾病 [J]. 国际病理科学与临床杂志, 2010, 10(30): 426-430.
[22] Shimaoka T, Nakayama T, Kume N, et al. Cutting edge: SR-PSOX/CXC chemokine ligand 16 mediates bacterial phagocytosis by APCs through its chemokine domain[J]. J Immunol,2003,171(4): 1647-1651.
[23] Manabe S, Iwase A, Goto M, et al. Expression and localization of CXCL16 and CXCR6 in ovarian endometriotic tissues [J]. Arch Gynecol Obstet, 2011,284(6): 1567-1572.
[24] Gaida MM, Giinther F, Wagner C, et a1. Expression of the CXCR6 Oil polymerphonuclear neutrophils in pancreatic carcinoma and in acute, localized bacterial infections [J]. Clin Exp Immunol, 2008, 154(2): 216-223.
[25] Hase K, Murakami T, Takatsu H, et a1. The membrane-bound chemokine CXCL16 expressed on follicle-associated epithelium and M cells mediates lympho-epithelial interaction in GALT [J]. J Immunol, 2006, 176(1): 43-51.
[26] Ainola M, Mandelin J, Liljeström M, et a1. Imbalanced expression of RANKL and osteoprotegerin mRNA in pannus tissue of rheumatoid arthritis[J]. Clin Exp Rheumatol,2008,26(2): 240-246.
[27] Isozaki T, Arbab AS, Haas CS, et al. Evidence that CXCL16 is a potent mediator of angiogenesis and is involved in endothelial progenitor cell chemotaxis: studies in mice with K/BxN serum-induced arthritis [J]. Arthritis Rheum, 2013, 65(7): 1736-1746.
[28] Yamauchi R, Tanaka M, Kume N, et a1. Upregulation of SR-PSOX/CXCL16 and recruitment of CD8 T cells in cardiac valves during inflammatory valvular heart disease[J]. Arterioscler Thromb Vase Biol, 2004, 24(2): 282-287.